BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 19879019)

  • 1. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia.
    Tong Z; Zhang J; Luo W; Wang W; Li F; Li H; Luo H; Lu J; Zhou J; Wan Y; He R
    Neurobiol Aging; 2011 Jan; 32(1):31-41. PubMed ID: 19879019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
    Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
    Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
    J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
    Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background.
    Lok K; Zhao H; Shen H; Wang Z; Gao X; Zhao W; Yin M
    Neurosci Lett; 2013 Dec; 557 Pt B():84-9. PubMed ID: 24176881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
    Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
    J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensorimotor gating and memory deficits in an APP/PS1 double transgenic mouse model of Alzheimer's disease.
    Wang H; He J; Zhang R; Zhu S; Wang J; Kong L; Tan Q; Li XM
    Behav Brain Res; 2012 Jul; 233(1):237-43. PubMed ID: 22595040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
    Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
    Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
    J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits.
    Jardanhazi-Kurutz D; Kummer MP; Terwel D; Vogel K; Dyrks T; Thiele A; Heneka MT
    Neurochem Int; 2010 Nov; 57(4):375-82. PubMed ID: 20144675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice.
    Arendash GW; Mori T; Cao C; Mamcarz M; Runfeldt M; Dickson A; Rezai-Zadeh K; Tane J; Citron BA; Lin X; Echeverria V; Potter H
    J Alzheimers Dis; 2009; 17(3):661-80. PubMed ID: 19581722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
    Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
    Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.
    Lafay-Chebassier C; Paccalin M; Page G; Barc-Pain S; Perault-Pochat MC; Gil R; Pradier L; Hugon J
    J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
    Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY
    Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirubin-3'-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer's disease.
    Ding Y; Qiao A; Fan GH
    Neurobiol Dis; 2010 Aug; 39(2):156-68. PubMed ID: 20381617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
    Pan X; Gong N; Zhao J; Yu Z; Gu F; Chen J; Sun X; Zhao L; Yu M; Xu Z; Dong W; Qin Y; Fei G; Zhong C; Xu TL
    Brain; 2010 May; 133(Pt 5):1342-51. PubMed ID: 20385653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.